SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001420720-23-000057
Filing Date
2023-10-16
Accepted
2023-10-16 16:59:14
Documents
5
Period of Report
2023-11-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20231127xpre14a.htm PRE 14A 1388584
2 GRAPHIC tmb-20231127xpre14a001.jpg GRAPHIC 7363
3 GRAPHIC tmb-20231127xpre14a002.jpg GRAPHIC 5872
4 GRAPHIC tmb-20231127xpre14a009.jpg GRAPHIC 28557
5 GRAPHIC tmb-20231127xpre14a010.jpg GRAPHIC 28073
  Complete submission text file 0001420720-23-000057.txt   1486622
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 001-35023 | Film No.: 231327808
SIC: 2834 Pharmaceutical Preparations